報價延遲最少15分鐘:2025/01/12 03:18 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.34 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-3.12/-1.90
|
|
企業價值
29.25M
|
| 資產負債 |
|
每股賬面淨值
0.98
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
176.84K
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/12 03:18 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders. |